Focused ultrasound and microbubbles have been extensively used to generate therapeutic bioeffects. Despite encouraging in vivo results, there remains poor control of the magnitude and spatial distribution of these bioeffects due to the limited ability of conventional pulse shapes and sequences to control cavitation dynamics. Thus current cycles) emitted at a low burst repetition frequency (<10 Hz), we decomposed this burst into short pulses by adding intervals to facilitate inter-pulse microbubble movement. To evaluate how this sequence influenced cavitation distribution, we emitted short pulses 
Introduction
Recent advances in ultrasound therapy involve the use of focused ultrasound (FUS) and systemically administered microbubbles (MBs) (Stride and Coussios 2010) for a range of therapeutic applications such as targeted drug delivery (Ferrara et al 2007) , sonothrombolysis (de Saint Victor et al 2014) , sonoporation (Yu and Xu 2014) , renal ultrafiltration (Deelman et 5 al 2010) and blood-brain barrier opening (Konofagou 2012) . FUS has the advantage of penetrating deep into the body and localising its interaction with MBs within a well-defined target region, i.e. the focal volume. MBs, which are typically composed of a gas-core and a lipid-shell, can be driven into radial oscillations by the rarefactional and compressional phases of the acoustic wave (Apfel 1997) . This acoustically driven behaviour, known as 10 acoustic cavitation, has been shown capable of producing either therapeutic or harmful bioeffects. Thus, understanding how cavitation dynamics are dictated by ultrasound parameters and designing new pulse shapes and sequences to produce new dynamics could improve therapeutic and safety outcomes.
Specific characteristics of an ultrasonic pulse shape (i.e. centre frequency, pulse length (PL), 15 and peak-rarefactional pressure (PRP)) and sequence (i.e. pulse repetition frequency (PRF)) have been shown to dictate specific types and magnitudes of cavitation. The centre frequency influences the frequency that MBs radially oscillate, with the oscillation amplitude being the greatest for MBs of resonant size at low acoustic pressures (Marmottant et al 2005 , Apfel and Holland 1991 , Lauterborn 1976 . The PRP determines the 20 amplitude of radial oscillation while the PL matches with the cavitation duration. PLs also influence the primary radiation force (Dayton et al 2002 (Dayton et al , 1997 ; long pulses push the MBs across a greater length, because the force is applied over a longer duration (Palanchon et al 2005) . Modification of these three pulse shape features can produce a range of cavitation behaviours from low-amplitude non-inertial cavitation to high-amplitude inertial cavitation, 25 in which MBs expand and collapse violently due to the inertia of the surrounding fluid (Apfel 1997) . Pulse shapes trigger cavitation dynamics on a time scale of microseconds and therefore interact with a single population of MBs. In therapeutic ultrasound, a large portion of the MBs are destroyed or modified by the end of the pulse and thus a pulse-off-time is required to allow new MBs to replenish the target volume. Conventional therapeutic pulse 30 sequences thus employ a pulse repetition frequency (PRF) typically on the order of Hz and a defined number of pulses, which determines the number of cavitation events the tissue is treated by and the duration of the treatment.
Depending on the ultrasonic pulse shape and the properties of the fluid surrounding the MBs, ultrasound exposure can cause the MBs to radially oscillate in either linear or non-linear cavitation modes: stable and non-inertial, stable and inertial, or transient and inertial 5 cavitation (Church and Carstensen 2001) . Cavitation modes can be identified by analysing the acoustic emissions from the MBs. High magnitude non-inertial and low magnitude inertial cavitation events radiate acoustic emissions at the driving ultrasound frequency and its integer multiples or harmonics (Apfel 1997) . In contrast, high magnitude inertial cavitation, which is created by the unstable expansion and subsequent violent MB collapse Inertial and non-inertial cavitation modes have been shown to cause bioeffects by exerting mechanical forces on biological interfaces, such as the vascular wall or the cell membrane.
Theoretical and experimental approaches have characterized MB-vessel interactions
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according to the mechanical stress exerted on the vascular wall and have correlated these measurements to vascular damage (Hosseinkhah et al 2013 , Hosseinkhah and Hynynen 2012 , Chen et al 2012 , Caskey et al 2007 , Qin and Ferrara 2006 . Bubble collapse was shown to exert up to four times higher stress than stable bubble expansion (Hosseinkhah et al 2013) .
Optical evidence suggested that the stress caused by stable cavitation originates from the 20 direct contact between the oscillating MBs and the endothelium of small vessels (Caskey et al 2007) . Although the exact mechanisms remain unclear, MB-mediated mechanical agitation of the vasculature has been shown to alter capillary permeability in the brain (Hynynen et al 2001) , kidney (Li et al 2013 , Fischer et al 2009 , liver (Wang et al 2013) , prostate and other organs. The advantage of these capillary opening techniques is that they can 25 noninvasively and locally increase the delivered concentration of drugs to a target tissue, thus reducing the required systemic doses and thereby minimizing deleterious side-effects. Drug delivery is particularly limited in the brain due to the blood-brain barrier (BBB) which tightly separates the vessel lumen from the brain interstitial space (Zlokovic 2008 ).
Neurodegenerative diseases like Alzheimer's, Parkinson syndrome and multiple sclerosis 30 remain untreatable partly because of the impermeability of the BBB to large therapeutic molecules such as antibodies or peptides (Konofagou 2012). For this reason, a large body of work has focused on the disruption of BBB using the FUS-MBs system (Wang et al 2014 , Nhan et al 2013 , Vlachos et al 2011 , Choi et al 2011b . Yet it has been previously shown that conventional pulse shapes and sequences are limited by an efficacysafety trade-off. Higher pressures increased doses delivered (Baseri et al 2010) , but they were also associated with cell necrosis or erythrocyte extravasations (Daffertshofer et al 2005, 5 Hynynen et al 2001).
Conventional ultrasound pulse shapes and sequences can control the type and magnitude of cavitation, but they are inefficient in distributing cavitation in physiological systems (Choi and Coussios 2012) . In capillary opening, cavitation-induced permeability increases are produced as spot-like patterns resulting in an inhomogeneous distribution of a model drug 10 (Choi et al 2007b , Stieger et al 2007 . This spatial inhomogeneity in treatment could be due to cavitation activity being poorly distributed throughout the microvasculature. Long PLs (>10ms) immobilize flowing MBs upon their entrance into the focal volume due to primary radiation forces (Dayton et al 2002) , thus constraining their activity to a limited region (Choi and Coussios 2012) . Typical therapeutic pulses have durations of 10-100ms and pulse and venules . In contrast, short PLs emitted at repetition periods on the order of microseconds were shown to enhance the desired in vivo bioeffect without compromising safety (O'Reilly et al 2011 , Choi et al 2011b . Further complicating the ability to control cavitation is that the pressure threshold for inertial cavitation decreases with the PL (Radhakrishnan et al 2013 , Gruber et al 2014 and thus long PLs promote faster MB 25 destruction. Additionally, high acoustic pressures and the concomitant inertial cavitation events introduce greater spatial bias on the cavitation distribution (Choi and Coussios 2012) .
For clinical applications, conventional ultrasonic pulses could produce over-treated and under-treated areas within the same focal volume, resulting in unsafe or inefficient therapies, respectively.
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The primary aim of the present study is to exploit flow in the design of a new therapeutic ultrasonic pulse sequence that will improve acoustic cavitation distribution over time and space, while avoiding or minimising damage-related cavitation activity. We evaluated the use of short PLs interspaced throughout a 100ms burst with off-time intervals placed between.
The use of this novel burst sequence was empirically shown to facilitate improved drug delivery distribution in vivo (Choi et al 2011b (Choi et al , 2011a , however there has been no direct evidence of improved cavitation distribution. The main assumption is that sonication of a MB 5 population during flow using our burst sequence would enable MBs to move during the short "off" state of the sequence. The distance MBs travel would depend on the time intervals between two adjacent pulses and the fluid velocity. During the "on" state, MBs are expected to be immobilised after a few cycles due to primary radiation force effects pushing them against the tubular (or vascular) wall in the direction of the FUS propagation. If MBs remain 10 intact during each pulse, the spatial distribution of MB activity could be adjusted solely by modifying the idle intervals between FUS pulses. Whereas conventional pulse shapes and sequences can control the cavitation type, magnitude and duration, our new burst sequence has the additional control of cavitation distribution.
Methods
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MB manufacturing
In-house manufactured lipid-shelled MBs were prepared and characterized prior to every experiment. Three phospholipids (Avanti Polar Lipids Inc., AL, USA), namely Dipalmitoylphosphatidylcholine (DPPC-82%), Dipalmitoylphosphatidic acid (DPPA-8%), and dipalmitolyphosphatidylethanolamine-PEG5000 (DPPE-PEG5000-10%) were mixed 20 and diluted with saline and glycerol. Perfluorobutane (FluoroMed L.P., Texas, USA) was added and the mixture was then amalgamated. The MB concentration and size distribution were measured using a haemocytometer and a microscope following previously described protocols (Sennoga et al 2010) . The MB concentration was found to be 7.3±4•10 9 MBs/ml and the mean size 1.62±0.87μm while excluding bubbles with diameters below 0.5μm. In MH-500P-C-P; Allen Avionics, Mineola, NY, USA) and a 28dB preamplifier (Stanford Research Systems, Sunnyvale, CA, USA) to an oscilloscope (8-bit, sampling rate 50MSa/s; 15 Tektronix, Bracknell, UK). The time-domain trace was then saved to a PC for processing.
Ultrasound parameters
The design of efficient pulse sequences was based on optimising specific parameters of the emitted ultrasound. Optimisation was performed in terms of spatiotemporal distribution of the cavitation energy emissions. Based on previous in vivo results (Choi et al 2011b (Choi et al , 2007a , we 20 refined the parametric search to a small subset of values (Table 1) . As discussed, the parameters used differ from conventional pulse sequences in the time scale. Whereas conventional pulse repetition periods are on the order of seconds, here the time interval between the pulses is on the order of microseconds and milliseconds (figure 1). Additionally, conventional pulse lengths are often circa 100ms. For this reason, a 100ms-long continuous wave pulse was used as the control sequence. highest oscillation amplitude and mode of cavitation at a given pressure (Church 2005) . For each distinct set of parameters, a total of 10 consecutive bursts were emitted.
Data analysis
The collected raw data were processed in Matlab. Analysis was conducted in terms of energy emission and spectral content. In addition to increased cavitation persistence, the pulse sequence should be able to produce a desired magnitude of cavitation, since this has been previously correlated to distinct bioeffects such as drug delivery increase (Choi et al 2014 , Graham et al 2014 tissue heating (Jensen et al 2012) or hemolysis (Chen et al 2003) . We therefore defined a parameter, the acoustic cavitation output, which is calculated as:
Energy analysis
Increased levels of this parameter suggest that the pulse sequences efficiently produce cavitation of both high magnitude (or mechanical stress through MB-vessel mechanical 20 interactions) and increased persistence. Cavitation output of the pulse sequences was used as an additional comparison metric to assess their potential bioeffect, regarding not only the cavitation magnitude but also its spatiotemporal distribution.
Spectral analysis
Acoustic emissions were spectrally analysed to determine the cavitation mode and duration, 25 both throughout a 100ms burst and across distinct pulses of a burst. For the latter method, each pulse was windowed and analysed independently.
In order to quantify the spectral features, we calculated the Harmonic to Broadband (HtB) non-harmonic value gave the HtB ratio. In order to compensate for the different bandwidth of the two regions (0.2MHz for the harmonic and 0.3MHz for the nonharmonic), the harmonic energy was weighted by a factor of 3/2, so that equal spectral magnitudes for the two regimes would result to a HtB ratio of 1.
Results
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Energy analysis
MB acoustic emissions were used to calculate the cavitation energy generated during each ultrasound burst. As expected, the mean total cavitation energy (averaged across the 10 consecutive bursts) rose with the PRP (figure 2). The minimum pressure for detecting cavitation activity with our system was approximately 100kPa. Any MB activity below this 15 threshold was not detectable owing to the low signal-to-noise ratio (SNR). The energy of the received emissions from pulsed excitation followed a linear trend with increasing pressure in all the sequences evaluated, while the continuous wave control reached a plateau after 250kPa, which was in good agreement with previous studies (Choi and Coussios 2012) .
There was no clear dependence of the PRF on the magnitude of the total burst energy. For the 20 PL of 5 cycles there was no notable difference between the various PRFs (figure 2(a)), which was unexpected if we take into account the different duty cycles or the different number of emitted pulses of each sequence. Lower PRFs (i.e. 0.62kHz and 1.25kHz) led to lower burst energies for the PL of 25 cycles ( figure 2(b) ), since a lower number of pulses were emitted during the 100ms burst. The 2.5kHz pulse sequence generated higher energy emissions 25 compared to the other PRFs (for pressures above 200kPa), an effect which was previously observed for pulsed sonication Church 1984, Ciaravino et al 1981) . Whereas the total burst energies provided insight into the magnitude of cavitation activity within the focal volume, we also sought to characterize the spatiotemporal distribution of this 5 activity by analysing features of the cumulative energy over time (figure 3). Within a 100ms burst sonication, the cumulative energy rose rapidly in the first few milliseconds and then plateaued. In nearly all the evaluated sequences, there was no further increase after the first 40ms, thus indicating a superfluous pulse-on time beyond this point ( figure 3(a) ). The stepwise increase depicts the "on" and "off" states of the sonication, with each step's width 10 matching the duration of a single pulse. We assumed that slower rise times of the cumulative energy are related to improved spatial distribution of cavitation activity since MBs are flowing. Following normalisation to the total burst energy, the t 50 and t 80 constants, or the time needed for energy emissions to reach 50% and 80% of the total value, were calculated ( figure 3(a) ). Lower acoustic pressures had higher time constants for both 5 and 25 cycle PLs
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and for all PRFs (figures 3(b)-(e)), providing evidence for prolonged cavitation activity.
Moreover, comparison between 5 (figures 3(b) and 3(d)) and 25 cycles (figures 3(c) and 3(e))
revealed consistently higher t 50 and t 80 values for the shorter PL. Unlike 25-cycle pulses, short 5-cycle pulses increased and stabilised the t 50 and t 80 values for higher pressures (PRP>200kPa). It is also evident that lower PRFs (or long pulse repetition periods) led to 20 higher time constants, since the same number of pulses is emitted in a longer period of time.
An exception to this trend is a PRF of 0.62kHz which produced lower time constants than 1.25kHz at low pressures and a PL of 25 cycles (figures 3(c) and 3(e)). This may originate from the relatively low achieved SNR in the corresponding time-domain signal and/or inefficient noise correction. As previously discussed we excluded values below 100kPa for all data sets and data points of PRP=110kPa (PRF=0.62kHz and 1.25kHz) for the PL of 5 cycles due to low SNR. 
Spectral analysis
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In addition to the analysis of the emitted MB energy, we were interested in identifying the cavitation mode through spectral analysis. Fourier Transforms of the PCD signal acquired during the entire ultrasound burst had similar structures to one another, presenting peaks at the harmonics to the driving frequency (an example is given in figure 5 (a) for PRP=147kPa, PL=25cycles). The bandwidth of the harmonics was greater for the evaluated pulse sequences rendered the accurate quantification of the HtB ratio difficult and thus was not processed here. However, it was expected that a similar trend was present in both the 5-and 25-cycle cases. 
Discussion
Acoustic cavitation distribution
We have demonstrated that the spatiotemporal distribution of acoustic cavitation activity seeded by flowing MBs can be adjusted by modifying specific features of an ultrasonic pulse on empirical evidence of BBB disruption (Choi et al 2011b (Choi et al , 2011a . In this paper we have confirmed that the reported improvement is directly correlated with the persisting MB-seeded acoustic cavitation activity (figures 3,6). (Radhakrishnan et al 2013) . Thus, by defining the number of the emitted ultrasound cycles at a specific pressure, one can adjust the longevity of FUS-MBs interactions and control the spatiotemporal distribution of acoustic cavitation.
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Our method for the distribution characterisation was implemented in vitro while assuming that the "idle" period between pulses would result in MB movement, though direct optical distance measurements were lacking. MB mobility was thus assessed by the calculated here could change the cavitation-induced inhomogeneous pattern of permeability increase (Nhan et al 2013 , Stieger et al 2007 into a more uniform pattern, as shown by Choi et al. (2011b Choi et al. ( , 2011a .
All the aforementioned calculations are valid only if fast bubble destruction is avoided, i.e.
for stable cavitation behaviour. It is argued here that stable cavitation is the dominant 
Limitations of the study
The findings of the present study were based on the data obtained using a single-element PCD. This method is an efficient and inexpensive tool to evaluate cavitation activity, but is whereas in our proof-of-principle study only one set flow rate was used. To reinforce our findings regarding MB mobility, the effect of various flow rates will be investigated in future 5 experiments using PAM. Nevertheless, our simple in vitro model can prove useful in creating safe and efficient ultrasound pulse sequences for use in every kind of therapeutic application.
Clinical relevance
Low power and short-PL sequences can be used for a wide range of clinical applications such as capillary opening techniques for targeted drug delivery, sonothrombolysis, and 10 sonoporation. Short PLs with low amplitude offer the advantage of limited interference, reduced standing-wave formation and negligible thermal effects. Particularly for FUS-based therapies in the brain, the formation of standing waves within the skull is expected to be avoided when employing short PL therapeutic pulses. Furthermore, the focal volume can be more accurately defined since skull-specific aberrations and sidelobe magnitude could be 15 easily ignored for short-PL sonication (Jones et al 2013 , O'Reilly et al 2014 . We have shown here that cavitation output for short 5-cycle pulse shapes is similar to longer 25-cycles shapes (figure 4). It is therefore expected that a shorter pulse is likely to have a similar bioeffect in the BBB disruption, as shown before (Choi et al 2011b (Choi et al , 2011a . Sonothrombolysis is also likely to be favoured by the time-resolved cavitation activity of the flowing MBs. With known size and location of a thrombus in a vessel, our pulse sequences could be used to uniformly treat the entire pathology. The time constants found here (figure 3) could be employed to calculate the proper PL and inter-pulse interval that would allow
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MBs to travel and acoustically treat the whole length of the thrombus before reaching their fragmentation point. Furthermore, the proper selection of the acoustic pressure and the relative cavitation output (figures 2 and 4) could provide efficient and safe therapy, minimising damage-related high-amplitude inertial cavitation. Similar ideas and methodologies can be applied in other MB-mediated therapeutic applications.
Conclusion
In conclusion, we were able to incorporate the presence of flow in the control of the 
